Technology US FDA qualifies first AI tool to help speed liver disease drug development By Reuters - December 8, 2025 0 87 FacebookTwitterPinterestWhatsApp The U.S. Food and Drug Administration has qualified the first artificial intelligence tool designed to help doctors assess a severe form of fatty liver disease in drug trials, the agency said on Monday. Read more…